Evidence map›Paper›PMID 16964552›Full record

ArticleJournal of clinical immunology2006

Inhibition of alpha nascent polypeptide associated complex protein may induce proliferation, differentiation and enhance the cytotoxic activity of human CD8+ T cells.

Nasser Al-Shanti, Ziyad Aldahoodi

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Nasser Al-ShantiInstitute for Clinical Research into Human Movement, Manchester Metropolitan University, Hassall Road, Alsager, Stoke-on-Trent, England. n.al-shanti@mmu.ac.uk
Ziyad Aldahoodi
Kōchi University · JPManchester Metropolitan University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The molecular mechanisms that control CD8(+) T cell proliferation and differentiations are poorly understood. Consequently, better understanding of the molecular pathways that regulate these processes may have an impact on the numbers and efficiency of antigen-specific cells that can be generated for cellular immunotherapy applications. Using differential display, we previously determined that alpha nascent polypeptide associated complex (alpha NAC) was identified as a potential target as its protein expression was found to be down-regulated as differentiation progressed in cultured human CD8(+) T cells. Here anti-sense technology was used to further investigate the role which alpha NAC may play in proliferation and differentiation. Human purified CD8(+) T cells were cultured in the presence of sense, non-sense and anti-sense oligonucleotides against the mRNA of alpha NAC. We reported that in the presence of anti-sense oligonucleotides expanded CD8(+) T cells exhibited higher levels of differentiation and activation markers and also increased proliferation response compared to cells cultured with sense-oligonucleotides. Furthermore, the functional cytotoxicity of CD8(+) T cells cultured with anti-sense was increased to 66% (+/-4.7%) compared to 42% (+/-3.2%) in cells expanded in the presence of oligonucleotides controls. Taken together, our results demonstrated that inhibition of alpha NAC protein induced not only cell proliferation but also differentiation and cytotoxic activity of CD8(+) T cells.

Indexed as

Blotting, WesternCD8-Positive T-LymphocytesCell DifferentiationCell ProliferationCells, CulturedCytotoxicity, ImmunologicElectrophoresis, Polyacrylamide GelFlow CytometryHumansImmunophenotypingMolecular ChaperonesMolecular Chaperonesnascent-polypeptide-associated complex

Identifiers

PMID16964552
OpenAlexW2055061503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.